Oriciro Genomics

Developer of technologies for DNA synthesis and amplification

placeTokyo, Tokyo, Japan calendar_todayFounded 2018 groups10 employees language oriciro.com

Innovation

6 patent families (4 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 307 times.

YearFilings
20182
20192
20204
20213
20225
20233

Investor mix

5 investors on record; lead investors include UTEC.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%
Coming soon